These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 18601600)
1. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Starr B; Hadfield SG; Hutten BA; Lansberg PJ; Leren TP; Damgaard D; Neil HA; Humphries SE Clin Chem Lab Med; 2008; 46(6):791-803. PubMed ID: 18601600 [TBL] [Abstract][Full Text] [Related]
2. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation. Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073 [TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
4. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028 [TBL] [Abstract][Full Text] [Related]
6. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH. Huijgen R; Hutten BA; Kindt I; Vissers MN; Kastelein JJ Circ Cardiovasc Genet; 2012 Jun; 5(3):354-9. PubMed ID: 22553281 [TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915 [TBL] [Abstract][Full Text] [Related]
9. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482 [TBL] [Abstract][Full Text] [Related]
10. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers. Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147 [TBL] [Abstract][Full Text] [Related]
11. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947 [TBL] [Abstract][Full Text] [Related]
13. [Tracing of patients with familial hypercholesterolemia in the Netherlands]. Umans-Eckenhausen MA; Defesche JC; Scheerder RL; Cliné F; Kastelein JJ Ned Tijdschr Geneeskd; 1999 May; 143(22):1157-61. PubMed ID: 10371839 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil. Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098 [TBL] [Abstract][Full Text] [Related]
15. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population. Abdul-Razak S; Rahmat R; Mohd Kasim A; Rahman TA; Muid S; Nasir NM; Ibrahim Z; Kasim S; Ismail Z; Abdul Ghani R; Sanusi AR; Rosman A; Nawawi H BMC Cardiovasc Disord; 2017 Oct; 17(1):264. PubMed ID: 29037163 [TBL] [Abstract][Full Text] [Related]
17. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening]. Sinan ÜY; Sansoy V Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of heterozygous familial hypercholesterolaemia in children. Nicholls DP; Cather M; Byrne C; Graham CA; Young IS Int J Clin Pract; 2008 Jul; 62(7):990-4. PubMed ID: 18492057 [TBL] [Abstract][Full Text] [Related]